Development and Characterization of In Situ Oral Gel of Spiramycin

Table 4

Stability studies of in situ gelformulation (F-12).

Time period for sampling	pH	Drug content (%)
Initial	7.53 ± 0.120	86 ± 0.12
After 1 month	7.51 ± 0.110	85 ± 0.14
After 2 months	7.53 ± 0.005	84 ± 0.20
After 3 months	7.50 ± 0.105	82 ± 0.10